The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation

Abstract

The MAPK cascades are central signaling pathways that regulate a wide variety of stimulated cellular processes, including proliferation, differentiation, apoptosis and stress response. Therefore, dysregulation, or improper functioning of these cascades, is involved in the induction and progression of diseases such as cancer, diabetes, autoimmune diseases, and developmental abnormalities. Many of these physiological, and pathological functions are mediated by MAPK-dependent transcription of various regulatory genes. In order to induce transcription and the consequent functions, the signals transmitted via the cascades need to enter the nucleus, where they may modulate the activity of transcription factors and chromatin remodeling enzymes. In this review, we briefly cover the composition of the MAPK cascades, as well as their physiological and pathological functions. We describe, in more detail, many of the important nuclear activities of the MAPK cascades, and we elaborate on the mechanisms of ERK1/2 translocation into the nucleus, including the identification of their nuclear translocation sequence (NTS) binding to the shuttling protein importin7. Overall, the nuclear translocation of signaling components may emerge as an important regulatory layer in the induction of cellular processes, and therefore, may serve as targets for therapeutic intervention in signaling-related diseases such as cancer and diabetes. This article is part of a Special Issue entitled: Regulation of Signaling and Cellular Fate through Modulation of Nuclear Protein Import.

Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis

“…Thus, treatment with klotho can lead to either activation or inhibition of the ERK pathway, the downstream effector of both pathways. Although this may seem to be counterintuitive, it is important to note that the activity of the ERK pathway is tissue and cell type dependent (38). The ERK pathway regulates a wide array of physiologic and pathologic processes, including proliferation, development, and metabolism, and while in the kidneys, as a downstream effector of FGF23 signaling, it participates in regulating phosphorus homeostasis (39), in cancer cells it enhances proliferation as a downstream effector of multiple growth factors, including IGF-1 (40).…”

Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells

“…The activated EGFR then activates the ERK cascade, including phosphorylation and activation of ERK 1/2. Upon its activation, the latter is translocated to the nucleus by a recently discovered specific mechanism, which involves binding of ERK-NTS to importin-7 (15)(16)(17)(18)(19).…”

“…14), which will eventually phosphorylate MAK and ERK1/2, leading to their translocation into the nuclei of the cancer cells (15)(16)(17)(18)(19) The intestinal renewal system is tightly controlled and depends on the spatial organization of signals that emanate from supportive mesenchymal cells, as well as from differentiated epithelial progeny. Intriguingly, recent evidence suggests that intestinal cancers may still contain a hierarchical organization, with cancer stem cells (CSCs) at the apex (20).…”

The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer

“…[27][28][29] Once activated, p38 proteins translocate from the cytosol to the nucleus where they phosphorylate the serine/threonine residues of their many substrates. The relationship between p38 MAPK and cancer is complex.…”